Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
01/2009
01/29/2009WO2008116339A3 Organic compounds
01/29/2009US20090030051 Inhibitors of IMPDH enzyme
01/29/2009US20090030038 Novel 8-Sulfonylamino-3 Aminosubstituted Chroman or Tetrahydronaphtalene Derivatives Modulating the 5Ht6 Receptor
01/29/2009US20090030000 Antiviral agents
01/29/2009US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
01/29/2009US20090029947 Sphingosine-1-phosphate receptor agonist and antagonist compounds
01/29/2009CA2697166A1 Isophthalamide derivatives inhibiting betasecretase activity
01/29/2009CA2693922A1 Process for preparing oxazolidine-and oxazolidinone-aminodiols
01/28/2009EP1177181B1 Substituted bicyclic compounds
01/28/2009CN101355939A Composition and synthesis of new reagents for inhibition of HIV replication
01/28/2009CN101353313A Process to produce oxazolidinones
01/28/2009CN100455565C Sulfonamide anions as catalysts for nco oligomerization
01/27/2009US7482467 New class of antibiotic with potent antibacterial activity against even methicillin resistant Staphylcoccus aureus (MRSA); 3-methylthio-4-phenyl-5-methoxyacetyl-oxazolidin-2-one for example
01/27/2009US7482466 Hydroxamates as therapeutic agents
01/27/2009US7482448 Compounds and compositions as cathepsin inhibitors
01/27/2009CA2377126C Thiazole and oxazole derivatives and their pharmaceutical use
01/27/2009CA2361187C A process for the preparation of taxanes from 10-deacetylbaccatin iii
01/27/2009CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
01/25/2009WO2009078694A1 Formulations comprising an asphaltene-dispersing/-inhibiting additive based on oxazolidines derived from polyalkyl or polyalkenyl n-hydroxyalkyl succinimides
01/25/2009CA2708368A1 Formulations comprising an asphaltene-dispersing/inhibiting additive based on oxazolidines derived from polyalkyl or polyalkenyl n-hydroxyalkyl succinimides
01/22/2009WO2009012203A1 Processes and intermediates for the preparation of heterocyclic sulfonamide compounds
01/22/2009WO2009012201A2 Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides
01/22/2009WO2009011880A2 Heterocyclic modulators of pkb
01/22/2009WO2009010694A2 Dyeing method using a styryl- or imine-type disulfide/thiol compound and stimuli, composition and device for implementing same
01/22/2009US20090023930 Processes and intermediates for the preparation of heterocyclic sulfonamide compounds
01/22/2009US20090023916 Tetrazine-based bio-orthogonal coupling reagents and methods
01/22/2009US20090023903 Process for the preparation of trifluoroalkyl-phenyl and heterocyclic sulfonamides
01/22/2009US20090023791 PH-dependent NMDA receptor antagonists
01/22/2009US20090023735 Sulphonamide Derivatives
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/22/2009US20090023708 Compounds Comprising a Lactam or a Lactam Derivative Moiety, Processes for Making Them, and Their Uses
01/22/2009US20090023703 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
01/22/2009CA2692713A1 Heterocyclic modulators of pkb
01/21/2009EP2016061A1 Compounds which potentiate ampa receptor and uses thereof in medicine
01/21/2009EP0958291B1 3-heterocyclyl-substituted benzoyl derivatives
01/21/2009CN101348469A C60 derivative containing cyclic phenyl imine ester structure and method for preparing the same
01/21/2009CN100453533C Acceptor excitant of a class of pancreas hyperglycemia peptide-1, preparation method and usage
01/20/2009CA2502856C Intermediates for retroviral protease inhibiting compounds
01/20/2009CA2295599C Novel heterocyclic analogs of diphenylethylene compounds
01/15/2009US20090018343 Fluorous Oxazolidinone Chiral Auxiliary Compounds and Methods of Manufacture
01/15/2009US20090018342 New epothiolone derivatives, process for their production, and their pharmaceutical use
01/15/2009US20090018150 5-Ht2b Receptor Antagonists
01/15/2009US20090018140 Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
01/14/2009EP2014652A1 Activating agent for peroxisome proliferator activated receptor
01/14/2009EP1622952B1 Azlactone chain transfer agents for radical polymerization
01/14/2009CN101343252A Method for separating 2,4-diphenyl oxazole and 2,4-diphenyl imidazole mixture
01/14/2009CN100451008C Antidiabetic oxazolidinediones and thiazolidinediones
01/13/2009US7476742 treatment of disease such as diabetes, obesity, hyperlipidemia, and atherosclerotic disease; e.g. ethyl (5-methoxy-2,3-dihydro-1H-inden-1-ylidene)ethanoate
01/13/2009US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection
01/13/2009US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents
01/08/2009WO2009005076A1 Amide compound
01/08/2009WO2009004430A1 N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors
01/08/2009WO2009004032A1 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests
01/08/2009WO2008119506A3 Insecticidal derivatives of substituted phenylalkylamines
01/08/2009WO2008119457A3 Lactam-substituted dicarboxylic acids and use thereof
01/08/2009US20090012303 Clean, high-yield preparation of s,s and r,s amino acid isosteres
01/08/2009US20090012293 Use of aryl chlorides in palladium-catalyzed c-h bond functionalization
01/08/2009US20090012137 Antmicrobial and radioprotective compounds
01/08/2009US20090012089 Oxazolidinone Compounds and Their Use as Metabotropic Glutamate Receptor Potentiators
01/08/2009US20090012070 Pesticidal heterocycles
01/08/2009CA2692265A1 Amide compounds
01/08/2009CA2691573A1 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests
01/07/2009EP2010477A2 Poly (ethylene glycol) containing chemically disparate endgroups
01/07/2009EP2009992A2 Il-8 receptor antagonists
01/07/2009EP1218361B1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents
01/07/2009CN101337856A Method for preparing methyl ketone compounds with heterocyclic ring
01/07/2009CN100448876C Heterocyclocarboxamide derivatives
01/07/2009CN100448852C Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding
01/07/2009CN100448444C Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors
01/06/2009US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
01/06/2009US7473699 antibiotic; Gram-positive pathogens (Staphylococci, Enterococci, and Streptococci ), MRSA and MRCNS; resistance to vancomycin and E. faecium to both aminoglycosides and beta--lactams; gram negative strains H.influenzae, M.catarrhalis and chlamydia; improved activity against mono-amine oxidase (MAO)
01/06/2009CA2421008C Substituted heterocyclic compounds for treating multidrug resistance
01/01/2009US20090005572 Methods for preparing diazonamides
01/01/2009US20090005475 Resin composition
12/2008
12/31/2008WO2009000533A1 Novel herbicides
12/31/2008WO2008135181A3 Insecticidal substituted 2-aminoindanes
12/31/2008EP2009006A1 Ureide derivative and use thereof for medical purposes
12/31/2008EP2009005A1 Azolecarboxamide derivative
12/31/2008EP2007745A2 Fungicide n-cyclopropyl-sulfonylamide derivatives
12/31/2008EP2007740A1 Process for preparing linezolid
12/31/2008EP2007739A2 A convergent process for the synthesis of taxane derivatives
12/31/2008EP2007717A1 Novel sulfonamide compounds
12/31/2008EP2007705A1 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
12/31/2008CA2690191A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/31/2008CA2690176A1 Novel herbicides
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470794 Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase inhibitors
12/30/2008CA2212207C Use of isoxazole and crotonamide derivatives for the modulation of apoptosis
12/25/2008US20080319200 Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
12/25/2008US20080319175 Transthyretin Stabilization
12/25/2008US20080319032 Tetrahydrobenzothiazole analogues as neuroprotective agents
12/25/2008US20080318956 Inflammatory cytokine release inhibitor
12/25/2008US20080317671 Non-imidazole heterocyclic compounds
12/24/2008WO2008157537A2 Compositions and methods of use for treating or preventing lipid related disorders
12/24/2008WO2008156601A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases
12/24/2008WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
12/24/2008WO2008076754A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
12/24/2008WO2008040994A3 Fluoro-substituted benzoxazole polymethine dyes
12/24/2008EP2004607A2 New compounds
12/24/2008EP2004185A2 Novel heterocyclic diphenyl ethers
1 ... 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 ... 210